IHC - PSA Test, Price, Normal Range | Sprint Diagnostics Hyderabad

No, fasting is not required for the IHC - PSA test as it uses tissue samples, not blood.

This test is typically recommended if a patient presents symptoms of prostate cancer or if a physical exam or initial blood test raises concerns.

The test identifies the presence of PSA protein in tissue samples. Higher levels may suggest prostate cancer, but other non-cancerous conditions can also cause elevated PSA levels.

The frequency of this test depends on the individual's risk factors for prostate cancer, such as age, family history, and race, as well as the result of initial screening tests. Your healthcare provider will provide guidance based on your specific situation.

The test is performed on tissue, so there's no absolute 'normal' value. Results will vary and should be interpreted by your healthcare provider considering other diagnostic findings.

No specific preparations are necessary for this test. You should continue your regular diet and medications unless otherwise directed by your healthcare provider.

Age, prostate volume, ethnicity, family history, and certain medications can influence PSA levels. Infections and medical procedures can also temporarily increase PSA levels.

Abnormal results should be discussed with your urologist or the healthcare provider who ordered the test to understand what they mean and to discuss the appropriate next steps.

The risks are mainly related to the biopsy procedure used to obtain the tissue sample, which can cause discomfort, bleeding, or infection.

Yes, certain medications, including those for urinary symptoms or to control hair loss, can lower PSA levels.

No, the IHC - PSA test is used as a part of the diagnostic process. If PSA levels are high, further investigations, such as a biopsy, are often needed to confirm the presence of cancer.

A positive result means that the PSA protein is present in the tissue sample. This can be an indication of prostate cancer, but it can also signify benign conditions. Your healthcare provider will interpret these results in the context of your overall clinical picture.

Yes, a digital rectal examination (DRE), a standard blood test for PSA, and often a prostate biopsy are part of the comprehensive diagnostic process.

The test is performed by a pathologist in a laboratory setting.

No, the IHC - PSA test is specific to the prostate gland, which is only present in men.

While the primary use of the IHC - PSA test is for the detection and monitoring of prostate cancer, it may be utilized in certain cases to investigate other prostate conditions like prostatitis or benign prostatic hyperplasia.

Lifestyle changes like diet, exercise, and reducing stress can improve overall health but do not directly influence the PSA levels, which are inherent to the prostate cells.

The test itself is not painful. However, the biopsy procedure used to collect the tissue sample may cause some discomfort.

The IHC - PSA test is more often used for diagnosis rather than predicting treatment response. However, following PSA levels over time can give some indication of how well treatment is working. In the realm of diagnosing and managing prostate cancer, the IHC - PSA (Prostatic Specific Antigen) Diagnostic Test is a vital tool. It is crucial to discuss the results with your healthcare provider to understand their implications. By doing so, you and your doctor can collaborate to devise the best possible course of action based on your unique health situation.